Sonoma Private Wealth LLC Sells 109 Shares of The Cigna Group (NYSE:CI)

Sonoma Private Wealth LLC reduced its position in The Cigna Group (NYSE:CI) by 8.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 1,203 shares of the health services provider’s stock after selling 109 shares during the quarter. Sonoma Private Wealth LLC’s holdings in The Cigna Group were worth $332,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Collier Financial purchased a new stake in shares of The Cigna Group in the fourth quarter worth approximately $32,000. ORG Wealth Partners LLC bought a new position in The Cigna Group during the 4th quarter valued at $34,000. Prospera Private Wealth LLC bought a new position in The Cigna Group during the 3rd quarter valued at $37,000. Compagnie Lombard Odier SCmA bought a new stake in shares of The Cigna Group in the 4th quarter worth $37,000. Finally, Harbor Capital Advisors Inc. bought a new stake in shares of The Cigna Group in the 3rd quarter worth $45,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of a number of recent analyst reports. Oppenheimer dropped their price target on shares of The Cigna Group from $400.00 to $375.00 and set an “outperform” rating on the stock in a research report on Friday, January 31st. Wells Fargo & Company cut their target price on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating on the stock in a research note on Tuesday, February 4th. Stephens reduced their target price on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a report on Friday, January 31st. Barclays dropped their price target on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, The Cigna Group currently has an average rating of “Buy” and an average target price of $372.31.

The Cigna Group Price Performance

NYSE CI opened at $308.66 on Monday. The company has a quick ratio of 0.72, a current ratio of 0.66 and a debt-to-equity ratio of 0.70. The company has a market cap of $85.85 billion, a PE ratio of 25.22, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The firm’s 50-day simple moving average is $289.54 and its two-hundred day simple moving average is $318.52.

The Cigna Group (NYSE:CI) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the firm earned $6.79 EPS. Research analysts predict that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be given a $1.51 dividend. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 annualized dividend and a dividend yield of 1.96%. The Cigna Group’s payout ratio is 49.35%.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.